Valmet's Engraving Solutions expands in North America to support customers closer than ever. September 9, 2026 Valmet's approach combines local production and support with pilot line testing and direct market knowledge, enabling closer collaboration with customers. Within this framework, solutions are developed with a targeted approach, addressing regional requirements, consumer preferences, and the specific characteristics of each production line. Based on these principles, Valmet is strengthening its commitment to customer success by expanding its Engraving Solutions offering in North America, opening a new operational site at Valmet's Green Bay facility in the United States. The new operational site represents an important step in this direction, bringing advanced engraving capabilities closer to the market and enabling more direct collaboration with tissue producers. The goal is to support the development of distinctive products that meet the demands of an increasingly competitive market. The site will have 3 new Direct Laser machines with the best technology available for Engraving process and it is planned to start production in two phases, being the first one by the end of 2026 and the second one in early 2028. This expansion builds on an already established footprint across Italy, Brazil, and the United States, combining global expertise with local responsiveness to ensure consistent quality and faster response times. In the tissue industry, product differentiation is becoming increasingly important. Consumers are focusing not only on performance, but also on aesthetics and tactile experience, which directly influences the perceived value of the product. In this context, engraving has taken on a new role. Once mainly a functional element, it has become a key factor in defining product identity, combining design and performance. The Green Bay site further strengthens this capability by integrating technologies already developed in other markets into a consistent offering. This allows customers to maintain global quality standards while benefiting from more responsive and targeted local support. Collaboration remains central to this approach. Valmet supports customers throughout the entire development process, from early concept to final pattern definition, combining technical expertise with application know-how. Customers can also leverage Valmet's global network of pilot lines located in key tissue hubs around the world. This unique capability allows tissue producers to validate concepts, test embossing and engraving solutions under real production conditions, and accelerate development regardless of their location. Access to pilot lines, advanced visualization tools, and local technical expertise enables testing under real conditions, validation of performance, and shorter development cycles, supporting faster decision-making and more efficient product launches. With this expansion, Valmet continues to develop a model that brings together expertise, technology, and operational proximity, helping customers respond more effectively to market demands and drive innovation in the tissue industry.

Eruslu enters tissue production with Valmet's technology. Sep 07, 2026 Eruslu Hygienic Products is preparing to add two Valmet Advantage DCT 200TS tissue lines at its Bursa site in Türkiye, with combined annual capacity of 140,000 tonnes. The first line is scheduled to start up in 2027, followed by the second in 2028. The investment marks Eruslu's entry into large-scale tissue production and will serve both the consumer and Away-from-Home (AfH) markets. From hygiene products to an integrated tissue value chain Eruslu already has a broad base in hygiene products, from baby and adult care to wet wipes and household products, with brands reaching more than 150 countries. The tissue mill investment follows Eruslu's earlier expansion into tissue converting. In February 2026, Futura and Plusline announced an order for six ANDROMEDA TISSUE converting lines for Eruslu, in a fully integrated "Jumbo to Pallet" configuration. The new Bursa mill takes that expansion a step further upstream into tissue production. By combining large-scale tissue manufacturing with its established converting and hygiene products operations, Eruslu is moving toward a more integrated tissue value chain, with greater control over quality, capacity and future product development. Both Valmet tissue machines are designed for 2,200 meters per minute, supported by automatic pulper feeding, rewinding, mill design and a broad automation scope. With trust in technology and people Eruslu's choice to go with Valmet was shaped by trust in both technology and people. The company wanted proven tissue-making technology, extensive automation and digital support, but also a team able to help turn a greenfield investment into a working mill. "Our ambition is clear - we want to achieve the best possible results from the very beginning. We know Valmet's capabilities and we trust their people, services and technology alike," says Erdem Barut, Paper Investments Production Director at Eruslu Hygienic Products. The two Advantage DCT lines will be supported by the Valmet DNA Automation System and digital services designed to give operators a clear view of the process, support predictive maintenance and help maintain consistent production. Automatic bale handling will reduce manual work around fiber feeding and contribute to a safer working environment. Valmet will support Eruslu throughout the development and start-up of the new tissue mill, from engineering and installation to operator training, commissioning and production start-up. Valmet specialists will work alongside the Eruslu team, combining tissue-process expertise with local project support and ongoing lifecycle services to help ensure a smooth ramp-up and reliable mill performance. "This is a major step for Eruslu, and our role is to help turn that ambition into a competitive mill," says Björn Magnus, Director, Tissue Global Product Sales at Valmet. "The technology provides the platform, but successful start-up and performance also depend on close cooperation, shared problem-solving and capable people on both sides" says Björn Magnus, Director, Tissue Global Product Sales, Valmet. Previous: No Information

Valmet delivers recovery boiler modification to Stora Enso Varkaus mill in Finland to improve reliability and cost efficiency. Valmet will deliver a recovery boiler modification including a new secondary superheater to Stora Enso's Varkaus Mill in Finland. In addition, Stora Enso and Valmet have signed a three-year cooperation agreement covering process monitoring and operator training to support continuous performance improvement at the mill. The mill has an annual production capacity of 420 000 tonnes of containerboard and 335 000 tonnes of pulp. "We value Valmet's technical expertise and long experience with recovery boilers. We expect the new superheater and additional modifications to bring further stability to the mill's operation and lower its maintenance costs. With Valmet's support, we continue to develop our processes and maintain the equipment in optimal operating conditions for years to come," says Antti Aartolahti, Operation Manager, Stora Enso Varkaus Pulp Mill. "The boiler modification is a key lifecycle investment that helps Stora Enso ensure reliable production at the Varkaus Mill. It combines Valmet's proven recovery boiler technology with our service expertise, and we are proud to support the customer's production goals with this long-term cooperation," says Karoliina Gunnila, Sales Manager, Services, Recovery, Energy and Circularity, Valmet. Valmet's delivery includes replacement of the recovery boiler's secondary superheater with Valmet's tubular superheater. In connection with the installation, the current superheater arrangement will be modified. Additionally, Valmet will support Stora Enso Varkaus Mill with process monitoring services including remote support and operator training. While the new superheater will be installed in 2027, Valmet will provide maintenance services for the recovery boiler's annual shutdown already in 2026.